← Back to Catalog
Clinician access
Tesamorelin / Ipamorelin
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Blend
Blends
Tesamorelin / Ipamorelin
Synergistic blend that balances Tesamorelin's GHRH properties with Ipamorelin's GH pulse capabilities. Best used for body recomposition and optimized visceral fat loss.
- Delivery
- Subcutaneous Injection
- Starting Dose
- 100mcg Tesa + 100mcg Ipa per dose (or adjusted via specific blend ratio)
- Titration
- 1x nightly (pre-bed) on empty stomach, or 2x daily
- Maintenance Range
- Cycle: 8–16 weeks depending on goals
- Sourcing
- Compounded Blend
Quantity
Continue Browsing1
More in Blends
CJC-1295 / Ipamorelin
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
CJC-1295 / Ipamorelin
Subcutaneous Injection
Wolverine (BPC-157 + TB-500)
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Wolverine (BPC-157 + TB-500)
Subcutaneous or Intramuscular Injection
Glow (BPC-157 + TB-500 + GHK-Cu)
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Glow (BPC-157 + TB-500 + GHK-Cu)
Subcutaneous or Intradermal Injection
Sign in to view full clinical details
Reconstitution, contraindications, clinic pricing, patient handouts, monitoring cadence, and drug interactions are available to verified clinicians.